Guides
Estrogen Supplements Over the Counter: What's Actually in the Bottle
Medical disclaimer: This article is for general information, not medical advice.
HRT Picks is an independent comparison site, not a medical provider. Nothing here is a substitute for advice from a licensed clinician who knows your personal and family history. Decisions to start, change, or stop hormone therapy should be made with that clinician. If you have an urgent medical concern, contact a healthcare professional directly.
Summarize this article with
There is no FDA-approved over-the-counter estrogen treatment for menopause in the United States. Prescription estradiol is different from soy, equol, wild yam and DHEA supplements. In our August 18, 2026 FDA directory audit, 28 OTC listings named estradiol; none was an approved drug. Some listed actual hormones, so an unapproved cream should not be assumed inactive or harmless.
The next step depends on the problem you're trying to solve. Hot flashes call for a discussion of hormone eligibility or nonhormonal care. Persistent vaginal dryness may need local treatment. If cost brought you to the supplement aisle, compare consultation and medication costs before buying again. A clinician assesses treatment suitability; an online finder helps compare services. This guide separates those decisions and explains what the evidence supports.
Can you buy estrogen over the counter?
FDA-approved estrogen requires a prescription. Our August 18 audit found 28 OTC estradiol listings: 24 labeled unapproved homeopathic and four labeled unapproved drug other. None had approval. The FDA explains that an NDC listing records submitted product information; it does not establish safety, effectiveness or FDA approval.
That is a historical directory snapshot, not laboratory testing of the bottles or a count of every product sold today. The query selected human OTC drugs naming estradiol. Homeopathic dilution codes and listed cream strengths describe manufacturer submissions. They cannot tell us whether an individual bottle contains the stated amount, how much reaches the bloodstream, or whether it will relieve symptoms.
What our FDA directory audit establishes
28 matching listings on August 18, 2026: 24 unapproved homeopathic, four unapproved drug other, zero approved. The separate Drugs@FDA search found no approved estriol product. These are database findings, not tests of product purity or a current market census. An NDC number is not an approval number.
Compounded estriol also lacks FDA approval, but a prescription compounded by a licensed pharmacy is a different situation from a cream sold without assessment. FDA describes pharmacy and outsourcing-facility oversight. The distinction is approval versus compounding oversight, not regulated versus completely unregulated. Our bioidentical HRT guide explains how approved estradiol and compounded mixtures differ.
Sources
- FDA National Drug Code Directory: limitations of listing information
- Original openFDA audit, August 18, 2026: product_type HUMAN OTC DRUG and active ingredient estradiol; 28 listings, 24 unapproved homeopathic and four unapproved drug other. Separate Drugs@FDA estriol search returned no matches.
- FDA: Compounding and the FDA, Questions and Answers
What do over-the-counter estrogen supplements actually contain?
The label usually names a plant extract or hormone precursor, rather than prescription estradiol. An ingredient's name cannot establish its effect: a placebo-controlled study of 23 women found no significant symptom or hormone-level benefit from wild yam cream after three months of use (Komesaroff et al., 2001). Read ingredients before comparing products.
| Ingredient | What the evidence actually tested | What that means for a shopper |
|---|---|---|
| Soy isoflavones | Levis et al., 2011: 200 mg daily for two years; no prevention of menopausal symptoms. | A supplement containing soy isn't a substitute for prescribed estrogen. |
| Equol | The Menopause Society, 2023: inconsistent evidence; not recommended for hot flashes. | Being an equol producer doesn't establish whether an equol pill will help. |
| Black cohosh | Newton et al., 2006: herbal regimens did not outperform placebo for vasomotor symptoms overall. | Check the exact preparation and safety evidence, not just testimonials. |
| Wild yam cream | Komesaroff et al., 2001: no significant difference from placebo in the tested cream. | A wild yam label does not establish estrogen or progesterone replacement. |
| DHEA pills | Labrie et al., 2016 tested vaginal DHEA, not oral supplements. | A different route and indication means a different treatment. |
Take a photo of the complete ingredient panel to a clinician or pharmacist, including the amount per serving. A blend name can hide which ingredient has supporting evidence and which does not. Keep hot-flash treatment separate from products marketed for vaginal comfort: a study of one symptom does not establish a benefit for the other.
Do phytoestrogens actually work for hot flashes?
Phytoestrogen supplements have not established a reliable substitute for estrogen therapy. In a randomized trial, 122 women received soy isoflavones and 126 received placebo. After two years, soy did not prevent menopausal symptoms; more soy recipients reported hot flashes (Levis et al., 2011). That result applies to the preparation and population studied.
Soy foods, concentrated isoflavones and equol pills are different exposures. Evidence about one cannot automatically be assigned to the others. Nor does evidence that a molecule interacts with an estrogen receptor tell you how much symptom relief to expect. Our nonhormonal treatment comparison separates clinical evidence from a plausible mechanism.
An equol claim to question
The ability to produce equol from dietary soy is not the same question as whether taking equol relieves symptoms. A pill supplies the metabolite directly. Producer prevalence cannot be turned into your probability of treatment success, and it does not provide a basis for choosing a supplement.
What does the Menopause Society say about menopause supplements?
The Menopause Society does not recommend supplements or herbal remedies for hot flashes. A useful underlying trial followed 351 women for one year: black cohosh and the tested multibotanical regimens did not improve vasomotor symptoms over placebo overall (Newton et al., 2006). That finding supports caution about promises of reliable relief.
The Society's 2023 position statement grades the evidence for supplements and herbal remedies as Levels I-II and places them on its not-recommended list. That is a treatment recommendation for hot flashes. It does not mean every supplement has been proven ineffective for every purpose, or that ordinary soy foods need to be avoided.
The research is not uniformly negative. NCCIH's black cohosh guidance, updated in 2024, describes a 2023 review of 22 studies that found possible symptom benefits. It also reports rare liver-injury cases involving products labeled black cohosh, with causation uncertain. Different preparations and mixed findings make a blanket claim of proven benefit or universal ineffectiveness inappropriate.
Safety also needs its own evidence. FDA does not approve dietary supplements before sale, but manufacturers have manufacturing and labeling obligations. Adverse-event reporting and enforcement still apply. Supplements can interact with medicines, and natural does not mean safe. Bring the product list to an HRT assessment, especially if you already take prescription treatment.
Is DHEA an over-the-counter hormone that works?
Evidence for prescription vaginal DHEA does not establish that oral DHEA supplements treat menopause symptoms. A randomized trial tested a 6.5 mg vaginal preparation for 12 weeks in 482 women and found improved painful-sex scores compared with placebo (Labrie et al., 2016). Those results concern a specific dose, route and symptom.
The prescription product, Intrarosa, is a vaginal insert for moderate to severe painful sex associated with menopausal vulvar and vaginal atrophy. An oral supplement with the same molecule isn't interchangeable. Ask which treatment was studied, where it is delivered, and whether the study addresses your symptom before comparing prices.
For mild vaginal symptoms, nonprescription moisturizers or lubricants can provide relief. Persistent symptoms deserve assessment, since the cause may not be menopause alone. The Menopause Society's GSM statement, 2020, distinguishes these options from prescription local treatments. Our vaginal estrogen guide explains that next conversation; a full systemic HRT plan is not automatically the relevant purchase.
What actually works for hot flashes without estrogen?
Nonhormonal prescription treatment and behavioral care are options to discuss. For example, FDA approved elinzanetant after three clinical studies involving 1,423 participants (FDA Lynkuet trial snapshot, 2025). Approval applies to moderate to severe menopausal hot flashes. It does not mean the drug is suitable for everyone or available without assessment.
The Menopause Society, 2023, supports cognitive behavioral therapy, clinical hypnosis, certain SSRIs/SNRIs, gabapentin and fezolinetant at Level I. CBT can reduce symptom bother; it should not be presented as interchangeable with a drug's effect on hot-flash frequency. A clinician can explain the fit and limitations of each approach.
Monitoring belongs in the cost comparison. FDA's Veozah warning requires liver tests before treatment, monthly for the first three months, then at months six and nine. Its boxed warning addresses serious liver injury. Ask whether those tests and their review are included in the quoted service. The Veozah alternatives guide compares the treatment categories and their trade-offs.
How do you compare prescription estrogen options and costs?
Compare an ongoing care plan, not just the first bottle. MedlinePlus describes clinician reassessment every three to six months when hormone treatment is used for menopause symptoms (MedlinePlus, 2026). Ask what assessment, medication and follow-up cost separately. A low membership price may leave the prescription or future appointments to be paid elsewhere.
What to discuss at your appointment
Hot flashes or night sweats
Discuss hormone eligibility and nonhormonal options. The women's finder compares services for this care journey.
Vaginal dryness or painful sex
Ask whether local treatment fits the symptoms. Read the vaginal estrogen guide before comparing a systemic HRT plan.
Cost is the barrier
Separate consultation, prescription and follow-up charges. Compare HRT costs and insurance questions.
- Identify the treatment: exact ingredient, route and whether the product is FDA approved or compounded.
- Get the complete quote: assessment, prescription, pharmacy shipping, follow-up and any clinically required tests.
- Check the terms: billing period, minimum commitment, cancellation and what happens if no prescription is appropriate.
- Confirm access: the clinician serves your state and offers the treatment being discussed. An online signup cannot guarantee a prescription.
Use the HRT cost comparison for current itemized prices, then the women's provider comparison or women's finder to narrow services. Shopping comparisons cover approved partners; their scope and scoring rules are disclosed. Bring the shortlist to the assessment along with your symptom history and supplement labels. The useful outcome is a treatment decision you understand, including a nonprescription option or no medicine when that is appropriate. You don't have to buy a plan to make the appointment worthwhile.